Theravance Biopharma
TBPH
#6225
Rank
$0.41 B
Marketcap
Cayman Islands
Country
$8.62
Share price
1.53%
Change (1 day)
-22.55%
Change (1 year)
Categories
Earnings for Theravance Biopharma (TBPH)
Earnings in 2023 (TTM): -$49.27 M
According to Theravance Biopharma 's latest financial reports the company's current earnings (TTM) are -$37.19 M. In 2022 the company made an earning of -$92.82 M an increase over its 2021 earnings that were of -$0.23 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Theravance Biopharma from 2013 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$49.27 M | -46.92% |
| 2022 | -$92.82 M | -57.85% |
| 2021 | -$0.23 B | -23.16% |
| 2020 | -$0.29 B | 18.56% |
| 2019 | -$0.25 B | 6.9% |
| 2018 | -$0.23 B | -16.79% |
| 2017 | -$0.28 B | 50.48% |
| 2016 | -$0.19 B | -0.39% |
| 2015 | -$0.19 B | -21.42% |
| 2014 | -$0.24 B | 47.6% |
| 2013 | -$0.16 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Corcept Therapeutics
CORT | $0.12 B | -427.87% | 🇺🇸 USA |
 Collegium Pharmaceutical
COLL | $0.20 B | -662.45% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | $86.28 M | -332.03% | 🇺🇸 USA |
 Catalent CTLT | -$1 B | 2,580.97% | 🇺🇸 USA |